Anneke van der Walt

Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis

Steve Simpson, Edward De Brouwer, Tomáš Kalinčík et al. · Cronfa (Swansea University) · 2021 · 156 citations · Full text

Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions

Alexander Klistorner, Prima Sriram, Nikitha Vootakuru et al. · Neurology · 2014 · 112 citations · Full text

Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial

John Foley, Gilles Defer, Lana Zhovtis Ryerson et al. · The Lancet Neurology · 2022 · 103 citations

Relapsing-remitting Multiple Sclerosis, Clinical Neurology, Clinical Trials +8

Effect of Disease-Modifying Therapy on Disability in Relapsing-Remitting Multiple Sclerosis Over 15 Years

Tomáš Kalinčík, Ibrahima Diouf, Sifat Sharmin et al. · Neurology · 2020 · 87 citations · Full text

Risk of secondary progressive multiple sclerosis: A longitudinal study

Adam Fambiatos, Vilija Jokubaitis, Dana Horáková et al. · Multiple Sclerosis Journal · 2019 · 81 citations · Full text